ARCHIVES

Protocol Amendments Required For 98 NCI-Sponsored Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

Upton Prefers Keeping Bioassay Program In NCI

May 12, 1978

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

Shuttle Vector Technology Concept Approved

February 28, 1986

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001